Clinical Takeaway The REAL 2.0 study tracked Canadian youth for 15 years to examine how adolescent risk factors like body image concerns and disordered eating contribute to eating disorders, mental health conditions,...
Endocannabinoid System Research: Cannabis & PTSD Treatment
Clinical Takeaway People with PTSD and co-occurring substance use disorders who also use cannabis can still benefit meaningfully from trauma-focused treatments. Cannabis use does not appear to prevent or significantly undermine the...
Endocannabinoid System Clinical Research: 2024 RCT Finds
Clinical Takeaway A randomized controlled trial tested the Minder mobile app, co-developed with university students, to address mental health and substance use concerns during a high-risk transition period. The study evaluated whether...
Cannabinoids in Pediatric Medicine: Evidence-Based Review
Clinical Takeaway Cannabinoids have been studied across a range of pediatric medical conditions, with evidence drawn from interventional trials, observational studies, and patient surveys. The current body of research supports cautious clinical...
Oregon cannabis industry beats THC potency cap in edibles – MJBizDaily
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyTHCDosingSafetyIndustry Why This Matters Clinicians should understand that Oregon’s failed potency cap attempt leaves patients...
Maryland Senate Delays Vote on Bill Allowing Firefighters to Use Medical Cannabis Off-Duty
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicySafetyResearchMental Health Why This Matters Firefighters currently face barriers to accessing medical cannabis as an...
Support doubling Iowa’s medical cannabis dispensaries! – Blog
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustryPain Why This Matters Increased dispensary availability could improve patient access to medical cannabis in...
Bill allocating medical cannabis funds passes House – Mountain State Spotlight
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustry Why This Matters West Virginia’s $34 million in unspent medical cannabis program revenue represents...
Cannabis Compounds Exhibit Potential in Combatting Fatty Liver Disease
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDTHCAging Why This Matters Clinicians managing patients with fatty liver disease now have preliminary evidence...
Study reveals cannabis compounds reduce threat of fatty liver disease | Health – CBS19
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchCBDTHCHemp Why This Matters This finding is clinically relevant because non-alcoholic fatty liver disease affects...